Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
CVS Health is a vertically integrated healthcare behemoth spanning health insurance (Aetna), pharmacy benefit management (Caremark), and retail pharmacy. While its scale provides robust and defensive cash flow generation, near-term headwinds from Medicare Advantage rates and retail margin compression weigh on profitability.
A combined shock of Medicare Advantage rate cuts and accelerated retail footprint deterioration. Under this stress test, free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics. conversion drops, forcing a pause on share repurchases and straining the heavily indebted $80B balance sheet.
Persistent medical cost inflation combines with unfavorable Medicare Advantage reimbursement updates, compressing insurance margins structurally above 88% MLR without offsetting premium increases.
The legacy retail pharmacy segment suffers from shrinking front-store foot traffic and generic drug pricing pressures, sharply limiting overall deleveraging capacity.
Failure to pay down acquisition debt out of FCF or dividend coverage ratio exceeding 70%, triggering a credit downgrade and cost-of-capital spike.
| 項目 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| 売上高 | — | $322.47B | $357.78B+10.9% | $372.81B+4.2% | $402.07B+7.8% | +5.7% |
| 売上総利益 | — | $54.50B | $54.43B | $51.40B | $55.36B | +0.4% |
| 営業利益 | — | $16.29B | $14.60B | $9.70B | $10.39B | -10.6% |
| 純利益 | — | $4.31B | $8.34B+93.5% | $4.61B-44.7% | $1.77B-61.6% | -20.0% |
| EPS (希薄化後) | $5.95 | $3.26 | $6.47 | $3.66 | — | -11.4% |
| EBITDA | — | $12.35B | $18.20B | $13.70B | $9.86B | -5.5% |
| 研究開発 | — | — | — | — | — | — |
| 販管費 | — | — | — | — | — | — |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
